PHR1625

Rufinamide

Pharmaceutical Secondary Standard; Certified Reference Material

• Synonim(y): Rufinamide, 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide
• Wzór empiryczny (zapis Hilla): C₁₀H₈F₂N₄O
• Numer CAS: 106308-44-5
• Masa cząsteczkowa: 238.19
• Numer MDL: MFCD00865314
• Kod UNSPSC: 41116107
• Identyfikator substancji w PubChem: 329823517
• NACRES: NA.24

Właściwości

• klasa czystości: certified reference material; pharmaceutical secondary standard
• Poziom jakości: 300
• agency: traceable to USP 1606401
• rodzina API: rufinamide
• Certyfikat analizy: current certificate can be downloaded
• opakowanie: pkg of 500 mg
• metody: HPLC: suitable; gas chromatography (GC): suitable
• Zastosowanie: pharmaceutical (small molecule)
• format: neat
• temp. przechowywania: 2-30°C
• ciąg SMILES: NC(=O)c1cn(Cc2c(F)cccc2F)nn1
• InChI: 1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)
• Klucz InChI: POGQSBRIGCQNEG-UHFFFAOYSA-N
• informacje o genach: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

Opis

Opis ogólny

Rufinamide is an antiepileptic drug, used as an adjunctive for the treatment of seizures associated with Lennox−Gastaut syndrome. Its mode of action involves prolonging the refractory period of voltage-dependent sodium channels via stabilization of the sodium channel inactive state, thus effectively keeping the ion channels closed.

Zastosowanie

Rufinamide may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using reversed-phase high-performance liquid chromatography technique.

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Działania biochem./fizjol.

Broad-spectrum anticonvulsant.

Implikacje diagnostyczne

Effective therapy for partial seizures in adults and childhood seizures in Lennox-Gastaut syndrome.

Komentarz do analizy

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Inne uwagi

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Przypis

To see an example of a Certificate of Analysis for this material enter LRAA5294 in the slot below. This is an example certificate only and may not be the lot that you receive.

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS08,GHS07
• Hasło ostrzegawcze: Warning
• Zwroty wskazujące rodzaj zagrożenia: H336,H351,H361fd
• Zwroty wskazujące środki ostrożności: P202 - P261 - P271 - P280 - P304 + P340 + P312 - P308 + P313
• Klasyfikacja zagrożeń: Carc. 2 - Repr. 2 - STOT SE 3
• Organy docelowe: Central nervous system
• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable